TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI)

Historical Holders from Q3 2023 to Q3 2025

Symbol
TLSI on Nasdaq
CUSIP
89680M101
Type / Class
Equity / Common stock, $0.0001 par value
Shares outstanding
49.9M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
9.56M
Holdings value
$44.5M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
54
Number of buys
27
Number of sells
-13
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Frankenius Equity AB 14% -31% $35.4M $1.3M 6.99M +3.82% Frankenius Equity AB Jul 31, 2025
Utmost Group Plc 6.79% $15.7M $6.44M 3.39M +69.2% Utmost Group PLC Sep 30, 2025
Wahlstrom Mats 6% -33.3% $15.1M $966K 2.99M +6.81% Mats Wahlstrom Jul 31, 2025
Nantahala Capital Management, LLC 4.09% -24% $9.49M $187K 2.04M +2.01% Nantahala Capital Management, LLC Sep 30, 2025

Institutional Holders of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 9.56M $44.5M +$5.04M $4.65 54
2025 Q2 8.47M $46.2M +$30.1M $5.45 46
2025 Q1 2.95M $16.3M +$3.57M $5.52 33
2024 Q4 2.35M $11.8M +$904K $5.01 27
2024 Q3 2.17M $10M +$2.04M $4.61 31
2024 Q2 1.62M $8.93M +$3.61M $5.52 25
2024 Q1 926K $9.03M +$2.61M $9.75 23
2023 Q4 680K $5.74M +$4.27M $8.45 19
2023 Q3 137K $699K +$699K $5.12 9